Because our products are designed and built with system integration in mind, no matter which type of oral solid dosage (OSD) form you need to produce, we can help you to select the optimal solution.
By embracing digitalization, modularization, holistic product innovation and sustainability, we can supply both standard and custom-configured lines to suit specific projects. For example, fluid bed dryers and coaters can be combined with top- or bottom-drive high shear mixer/granulators, wet and dry milling facilities, product handling systems, binder and coating preparation units, filtration units and/or tablet presses. Furthermore, safety, containment, product flow and building requirements are fully incorporated for optimum process efficiency.
With a stronger focus on efficiency, Industry 4.0 and the environment, the pharmaceutical industry is evolving. GEA is committed to transforming tomorrow with better processes and has enthusiastically embraced these themes. For example, when the industry embraced continuous manufacturing to improve efficiencies and product quality, GEA was already bringing process-ready technology to the market.
And when it comes to digitalization, we’ve been innovating for years and bringing new services to customers, such as our virtual reality (VR)-based training modules. Ongoing product innovation, making our equipment better for the user and the planet, ensures that when you invest in a GEA process line, you’re making the right choice.
يتم عرض 4 من 31
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Competitively priced with short delivery times, BUCK® valves are fully GMP compliant, offer robust, free-oriented docking, a dust- and contamination-free interface, and quick and easy maintenance. And, with thousands of global implementations and 20 years of experience.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.
مع اعتماد عدد أكبر من المجتمعات والشركات على محطات المضخات الحرارية المركزية وتقنية التبريد المحايدة للمناخ، أصبحت هناك أهمية حيوية لضمان توفير إمدادات مستمرة لهذه التقنيات. يساعد برنامج الإدارة InsightPartner Blu-Red Care من...
في إطار التزام Lignatherm AG بإعادة إحياء صناعة ألواح العزل الخشبية السويسرية، تعتمد الشركة على حل GEA المبتكر المكون من ثلاث مراحل لمعالجة المياه لإعادة تدوير ما يقرب من 100% من مياه الصرف الناتجة عن تصنيع الألياف الخشبية. وستعمل...